CLINICAL_TRIALS
trial_result
· 2024-11-07
Clinical Trial Update: Evaluating the Efficacy and Safety of Roflumilast in Patients with NASH [Phase 2]
Summary
Phase 2 trial evaluates the efficacy and safety of roflumilast in patients with non-alcoholic steatohepatitis (NASH); study completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanta University | Conditions: Non-Alcoholic Steatohepatitis (NASH) | Phase 2 | Status: COMPLETED